One or Two Doses of Daclizumab Provide Effective Immunosuppression for Renal Transplant Patients with High Immunologic Risk or with Delayed Graft Function.

作者： George J. Chang , Robert O'Rourke , Ivy Lee , Peter G. Stock , Flavio Vincenti

DOI: 10.1097/00007890-199904150-00597

关键词: